Llwytho...
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
BRAF and MEK inhibitors (BRAFi/MEKi), the standard treatment for patients with BRAFV600 mutated melanoma, are currently explored in combination with various immunotherapies, notably checkpoint inhibitors and adoptive transfer of receptor-transfected T cells. Since two BRAFi/MEKi combinations with si...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
MDPI AG
2018-01-01
|
Cyfres: | International Journal of Molecular Sciences |
Pynciau: | |
Mynediad Ar-lein: | http://www.mdpi.com/1422-0067/19/1/289 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|